Maia

Developer of immunotherapeutic solutions for cancer treatment

placeChicago, Illinois, United States calendar_todayFounded 2018 groups18 employees language maiabiotech.com

Registered entities

Social engagement

Social engagement: 7.5K social following, 10 posts in the last 12 months — around the industry typical range.

Investor mix

4 investors on record; lead investors include Checkmate Capital, BRK Financial Group.

Investor typeCountShare
Venture capital125%
Private equity125%
Other / undisclosed250%

Recent activity

30 Jun 2026
Milestone
regulatory
25 Jun 2026
Milestone
regulatory
10 Jun 2026
Expansion
Central Alabama Research, Homewood, Alabama
Coming soon